Autopsy report · NCT01214174

Efficacy and Safety Study of IBI-10090 in Cataract Surgery Patients

“Study C11-01 started”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 7 months before it stopped.
• 42 participants enrolled.
• Results were posted on the registry 1 year 4 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

ICON Bioscience Inc

Sponsor type

Industry

Conditions

Ocular Inflammation

Interventions

IBI-10090

Participants

42

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.